caprelsa 300 mg
astra zeneca israel ltd - vandetanib 300 mg - film coated tablets - vandetanib - caprelsa is indicated for the treatment of aggressive and symptomatic medullary thyroid cancer (mtc) in patients with unresectable locally advanced or metastatic disease. for patients in whom rearranged during transfection (ret) mutation is not known or is negative, a possible lower benefit should be taken into account before individual treatment decision
budicort respules 0.5 mg/2 ml
astra zeneca israel ltd - budesonide 0.5 mg / 2 ml - suspension for inhalation - budesonide - bronchial asthma, especially in cases where other therapy is insufficient or unsuitable.
budicort respules 1 mg/2ml
astra zeneca israel ltd - budesonide 1 mg / 2 ml - suspension for inhalation - budesonide - bronchial asthma, especially in cases where other therapy is insufficient or unsuitable.
budicort 200 mcg/dose
astra zeneca israel ltd - budesonide micronized 4 mg/ml - suspension for inhalation - budesonide - bronchial asthma.
iressa
astrazeneca (israel) ltd - gefitinib - film coated tablets - gefitinib 250 mg - gefitinib - gefitinib - iressa is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating mutations of egfr-tk.
zoladex la depot injection 10.8 mgsyringe
astrazeneca singapore pte ltd - goserelin - injection - 10.8 mg/syringe - goserelin 10.8 mg/syringe
pulmicort respules nebulising suspension for inhalation 0.5 mgml
astrazeneca singapore pte ltd - budesonide micronised - solution - 1 mg/2 ml - budesonide micronised 1 mg/2 ml
pulmicort respules nebulising suspension for inhalation 0.25 mgml
astrazeneca singapore pte ltd - budesonide micronised - solution - 500 mcg/2 ml - budesonide micronised 500 mcg/2 ml
tenoret 50 tablet
astrazeneca singapore pte ltd - atenolol; chlorthalidone - tablet, film coated - 50 mg - atenolol 50 mg; chlorthalidone 12.5 mg
zoladex depot injection 3.6 mgsyringe
astrazeneca singapore pte ltd - goserelin acetate eqv peptide - injection - 3.6 mg/syringe - goserelin acetate eqv peptide 3.6 mg/syringe